← Leaderboards
James V Degregori
University Of Colorado Denver
$21,700,379
Attributed
$24,799,493
Total exposure
31
Grants
29
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,807,470 · 31
VA$0 · 1
By mechanism
R01$14,414,965 · 10
P30$8,015,954 · 13
U01$2,158,706 · 2
T32$1,501,626 · 1
P50$1,415,812 · 1
R21$1,300,407 · 4
Top collaborators
- Sheng Li6 shared
- Daniel A Pollyea2 shared
- Julio A Aguirre-Ghiso1 shared
- Mercedes R. Rincon1 shared
- Andrew M Thorburn1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Traci Lyons$4,705,520
- Daniel M Lindberg$2,532,052
- Alan Michael Elder$284,216
- Virginia F. Borges$4,416,776
- Daniel A Pollyea$825,062
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsMutationMouse ModelPhenotypeGeneticAgingOncogenicEvolutionMutantPreventElderlyMediatingFitnessStem CellsInflammationLeukemogenesisAgedPreventionTissuesEnvironmentGenesHematopoietic Stem CellsHematopoiesis
Grant awards (94)
University of Colorado Cancer Center Support Grant$4,007,977
P30 · FY2025 · CA · contact PI
Developmental Therapeutics Program$2,029,064
P30 · FY2025 · CA · contact PI
Shared Resource Management$1,332,221
P30 · FY2025 · CA · contact PI
Role of respiratory viral infections and inflammation in promoting metastatic outgrowth in the lung$672,011
R01 · FY2025 · CA · contact PI
IAP inhibition as a therapeutic strategy to target therapy-resistant leukemia initiating cells$387,630
R01 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$191,467
P30 · FY2025 · CA · contact PI
The impact of reduction of cellular senescence on age-related epigenetic heterogeneity$188,093
U01 · FY2025 · CA
Clinical Protocol and Data Management$100,864
P30 · FY2025 · CA · contact PI
Administrative Office$63,914
P30 · FY2025 · CA · contact PI
Community Outreach and Engagement$60,346
P30 · FY2025 · CA · contact PI
Developmental Funds$58,053
P30 · FY2025 · CA · contact PI
Tumor-Host Interactions Program$39,728
P30 · FY2025 · CA · contact PI
Cancer Research Training and Education Coordination$36,516
P30 · FY2025 · CA · contact PI
Molecular and Cellular Oncology Program$34,631
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$32,572
P30 · FY2025 · CA · contact PI
Cancer Prevention and Control Program$28,601
P30 · FY2025 · CA · contact PI
IAP inhibition as a therapeutic strategy to target therapy-resistant leukemia initiating cells$387,630
R01 · FY2024 · CA · contact PI
The impact of reduction of cellular senescence on age-related epigenetic heterogeneity$374,770
U01 · FY2024 · CA
Autophagy regulation of apoptosis and necroptosis within cell populations$333,260
R01 · FY2024 · CA · contact PI
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis$241,348
R01 · FY2024 · AG · contact PI
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis$372,507
U01 · FY2023 · CA
Autophagy regulation of apoptosis and necroptosis within cell populations$350,977
R01 · FY2023 · CA · contact PI
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis$245,862
R01 · FY2023 · AG · contact PI
The impact of reduction of cellular senescence on age-related epigenetic heterogeneity$201,295
U01 · FY2023 · CA
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers$0
I01 · FY2023 · VA · contact PI
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis$377,188
R01 · FY2022 · AG · contact PI
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis$372,507
U01 · FY2022 · CA
Autophagy regulation of apoptosis and necroptosis within cell populations$351,146
R01 · FY2022 · CA · contact PI
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis$250,234
R01 · FY2022 · AG · contact PI
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis$61,880
R01 · FY2022 · AG · contact PI
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers$0
I01 · FY2022 · VA · contact PI
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis$439,226
R01 · FY2021 · AG · contact PI
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis$423,109
U01 · FY2021 · CA
Autophagy regulation of apoptosis and necroptosis within cell populations$353,947
R01 · FY2021 · CA · contact PI
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis$254,472
R01 · FY2021 · AG · contact PI
Amy Briggs Diversity Supplement R01AG067584$30,554
R01 · FY2021 · AG · contact PI
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers$0
I01 · FY2021 · VA · contact PI
Down Syndrome as a systemic autophagy deficiency disorder$2,594,673
R01 · FY2020 · HD · contact PI
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis$378,263
R01 · FY2020 · AG · contact PI
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis$148,694
R01 · FY2020 · AG · contact PI
Understanding and circumventing aging-dependent changes in the bone marrow microenvironment that promote leukemogenesis$113,129
U01 · FY2020 · AG · contact PI
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers$0
I01 · FY2020 · VA · contact PI
Determining how aging-associated changes in the microenvironment contribute to leukemogenesis$378,762
R01 · FY2019 · AG · contact PI
Targeting MCJ/DNAJC15 and the mitochondrial electron transport chain in acute myeloid leukemia$191,087
R21 · FY2019 · CA · contact PI
Understanding and circumventing aging-dependent changes in the bone marrow microenvironment that promote leukemogenesis$113,296
U01 · FY2019 · AG · contact PI
Dissecting the Role of Inflammation in Smoking and Aging Associated Lung Cancers$0
I01 · FY2019 · VA · contact PI
Improving Outcome from EGFR Specific TKIs Using Rational Combinations$290,197
P50 · FY2018 · CA · contact PI
Targeting MCJ/DNAJC15 and the mitochondrial electron transport chain in acute myeloid leukemia$163,459
R21 · FY2018 · CA · contact PI
Aging-associated alterations in adaptive landscapes and the evolution of leukemia$50,001
R01 · FY2018 · CA · contact PI
Improving Outcome from EGFR Specific TKIs Using Rational Combinations$6,134
P50 · FY2018 · CA · contact PI
Aging-associated alterations in adaptive landscapes and the evolution of leukemia$344,920
R01 · FY2017 · CA · contact PI
Improving Outcome from EGFR Specific TKIs Using Rational Combinations$295,042
P50 · FY2017 · CA · contact PI
Aging-associated alterations in adaptive landscapes and the evolution of leukemia$344,974
R01 · FY2016 · CA · contact PI
Improving Outcome from EGFR Specific TKIs Using Rational Combinations$273,099
P50 · FY2016 · CA · contact PI
Nrf2-mediated impaired hematopoietic stem cell fitness following irradiation$202,928
R21 · FY2016 · CA · contact PI
Aging-associated alterations in adaptive landscapes and the evolution of leukemia$345,027
R01 · FY2015 · CA · contact PI
Rationally designed targeted therapeutic approaches for NSCLC$304,278
R01 · FY2015 · CA · contact PI
Improving Outcome from EGFR Specific TKIs Using Rational Combinations$276,435
P50 · FY2015 · CA · contact PI
Nrf2-mediated impaired hematopoietic stem cell fitness following irradiation$168,789
R21 · FY2015 · CA · contact PI
Aging-associated alterations in adaptive landscapes and the evolution of leukemia$309,492
R01 · FY2014 · CA · contact PI
Rationally designed targeted therapeutic approaches for NSCLC$295,150
R01 · FY2014 · CA · contact PI
Improving Outcome from EGFR Specific TKIs Using Rational Combinations$274,905
P50 · FY2014 · CA · contact PI
Pre-doctoral training in Molecular Biology$159,975
T32 · FY2014 · GM · contact PI
Aging-associated alterations in adaptive landscapes and the evolution of leukemia$53,912
R01 · FY2014 · CA · contact PI
Aging-associated alterations in adaptive landscapes and the evolution of leukemia$314,028
R01 · FY2013 · CA · contact PI
Rationally designed targeted therapeutic approaches for NSCLC$286,021
R01 · FY2013 · CA · contact PI
Pre-doctoral training in Molecular Biology$196,947
T32 · FY2013 · GM · contact PI
Rationally designed targeted therapeutic approaches for NSCLC$304,278
R01 · FY2012 · CA · contact PI
Pre-doctoral training in Molecular Biology$196,947
T32 · FY2012 · GM · contact PI
Rationally designed targeted therapeutic approaches for NSCLC$32,009
R01 · FY2012 · CA · contact PI
Rationally designed targeted therapeutic approaches for NSCLC$299,879
R01 · FY2011 · CA · contact PI
Pre-doctoral training in Molecular Biology$194,148
T32 · FY2011 · GM · contact PI
Diet-Induced Adaptive Leukemogenesis: BCR-Abl dependent upregulation of folate re$188,678
R21 · FY2010 · CA · contact PI
Pre-doctoral training in Molecular Biology$159,522
T32 · FY2010 · GM · contact PI
Poor competition in hematopoietic stem/progenitor pools favors tumorigenesis$214,532
R01 · FY2009 · CA · contact PI
Diet-Induced Adaptive Leukemogenesis: BCR-Abl dependent upregulation of folate re$155,465
R21 · FY2009 · CA · contact PI
Poor competition in hematopoietic stem/ progenitor pools favors tumorigenesis$214,532
R01 · FY2008 · CA · contact PI
Predoctoral Training in Molecular Biology$144,987
T32 · FY2008 · GM · contact PI
Regulation of the Lymphocytic cell cycle by E2F$237,102
R01 · FY2007 · CA · contact PI
Poor competition in hematopoietic stem/ progenitor pools favors tumorigenesis$214,532
R01 · FY2007 · CA · contact PI
Predoctoral Training in Molecular Biology$93,202
T32 · FY2007 · GM · contact PI
Regulation of the Lymphocytic cell cycle by E2F$244,184
R01 · FY2006 · CA · contact PI
Poor competition in hematopoietic stem/progenitor pools favors tumorigenesis$220,939
R01 · FY2006 · CA · contact PI
Predoctoral Training in Molecular Biology$177,949
T32 · FY2006 · GM · contact PI
Regulation of the Lymphocytic cell cycle by E2F$250,060
R01 · FY2005 · CA
Poor competition in hematopoietic stem/progenitor pools favors tumorigenesis$222,843
R01 · FY2005 · CA
Predoctoral Training in Molecular Biology$177,949
T32 · FY2005 · GM
Regulation of the Lymphocytic cell cycle by E2F$249,596
R01 · FY2004 · CA
Noncell autonomous control of Beta islet cells$115,375
R21 · FY2004 · DK
Regulation of the Lymphocytic cell cycle by E2F$247,744
R01 · FY2003 · CA
Noncell autonomous control of Beta islet cells$114,626
R21 · FY2003 · DK
SPECIFIC ROLES FOR E2F FAMILY MEMBERS$198,106
R01 · FY2002 · CA
SPECIFIC ROLES FOR E2F FAMILY MEMBERS$192,338
R01 · FY2001 · CA
SPECIFIC ROLES FOR E2F FAMILY MEMBERS$186,731
R01 · FY2000 · CA